Thomas A. Mitro
2015
In 2015, Thomas A. Mitro earned a total compensation of $2.3M as President & Chief Operating Officer at Aerie Pharmaceuticals, a 5% decrease compared to previous year.
Compensation breakdown
| Bonus | $195,700 |
|---|---|
| Option Awards | $1,406,951 |
| Salary | $391,400 |
| Stock Awards | $332,856 |
| Total | $2,326,907 |
Mitro received $1.4M in option awards, accounting for 60% of the total pay in 2015.
Mitro also received $195.7K in bonus, $391.4K in salary and $332.9K in stock awards.
Rankings
In 2015, Thomas A. Mitro's compensation ranked 4,124th out of 13,638 executives tracked by ExecPay. In other words, Mitro earned more than 69.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,124 out of 13,638 | 70th |
Division Manufacturing | 1,512 out of 5,190 | 71st |
Major group Chemicals And Allied Products | 553 out of 1,854 | 70th |
Industry group Drugs | 437 out of 1,528 | 71st |
Industry Biological Products, Except Diagnostic Substances | 76 out of 254 | 70th |
Source: SEC filing on April 27, 2017.
Mitro's colleagues
We found two more compensation records of executives who worked with Thomas A. Mitro at Aerie Pharmaceuticals in 2015.
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019